Wednesday, July 15, 2026
Home Medi News Page 124

Medi News

    Latest
    car-t-therapy-may-redefine-treatment-for-heart-disease
    Medi News

    CAR T Therapy May Redefine Treatment for the World’s Most Common...

    The Indian Practitioner -
    india-poised-to-become-the-laboratory-of-the-world
    Medi News

    India Poised to Become the ‘Laboratory of the World’, Says Health...

    The Indian Practitioner -
    mercks-keytruda-combo-secures-fda-approval
    Medi News

    Merck’s KEYTRUDA Combination Wins FDA Nod for High-Risk Bladder Cancer Patients

    The Indian Practitioner -
    wockhardt-hospitals-diagnoses-autoimmune-encephalitis
    Medi News

    Beyond Psychology: Wockhardt Hospitals Diagnoses Autoimmune Encephalitis

    The Indian Practitioner -
    Funding to Accelerate Product Development and Global Expansion Bengaluru-based semiconductor startup Sophrosyne Technologies has secured $2 million in a fully subscribed seed round led by Bluehill.VC. The new capital will accelerate the company’s transition from prototype silicon to full-scale product development and international OEM collaborations. Additionally, the funding will support growth in silicon design, firmware development, and early customer deployments across India and global markets. Building a Next-Generation Unified Biosensing SoC As per the press release, Sophrosyne is developing a unified multi-vital biosensing System-on-Chip (SoC) capable of measuring ECG, PPG, respiration, temperature, and related signals with exceptional accuracy and ultra-low energy consumption. By integrating multiple sensing functions into a single compact architecture, the company enables wearable devices to deliver richer, continuous health insights while reducing silicon footprint and complexity. Recently, Sophrosyne cleared technical diligence and received a MeitY DLI grant of $1.2 million, further validating its engineering strength. Investor Perspective on the Future of Wearable Health Sridhar Parthasarathi, Managing Partner at Bluehill.VC, highlighted the growing demand for accuracy and continuous monitoring in wearable health devices. “Wearable health is entering a new phase where precision and continuous tracking are becoming standard expectations. Achieving this requires semiconductor-level innovation, and Sophrosyne is among the few teams capable of delivering it,” he said. He added that Sophrosyne’s approach directly addresses key constraints faced by device makers—performance, efficiency, and integration complexity. “Bluehill.VC is uniquely positioned to support deep-tech founders building breakthrough semiconductor IP from India. We are proud to back Sophrosyne on this journey.” A Defining Moment for Sophrosyne Dr. Manish Srivastava, Co-founder and CEO of Sophrosyne, emphasized the strategic importance of the investment. “Bluehill.VC’s investment comes at a defining moment for us as we move toward production-grade silicon and early OEM rollouts,” he said. He noted that having a deep-tech investor backed by industry leaders such as Vinod Dham, Manu Iyer, and Sridhar Parthasarathi provides the startup with guidance few companies can access. “Beyond capital, Bluehill.VC brings discipline, clarity, and the capability to help us scale this technology globally,” he added.
    Medi News

    Bluehill.VC Invests $2M in Sophrosyne’s Mission to Redefine Wearable Health

    The Indian Practitioner -
    delhi-to-open-70-new-arogya-ayushman-mandirs-this-month
    Medi News

    Delhi to Open 70 New Arogya Ayushman Mandirs This Month

    The Indian Practitioner -
    fssai-orders-immediate-removal-of-misleading-ors-products
    Medi News

    FSSAI Orders Immediate Removal of Misleading ‘ORS’ Products

    The Indian Practitioner -
    ultrasound-technique-shows-strong-results-for-prostate-cancer
    Medi News

    New Ultrasound Technique Shows Strong Results for Early Prostate Cancer in...

    The Indian Practitioner -
    neurosurgeons-at-kims-saveera-perform-avm-surgery
    Medi News

    Neurosurgeons at KIMS Saveera Perform Rare, High-Risk AVM Surgery Successfully

    The Indian Practitioner -
    pneubevax-14-receives-who-pre-qualification
    Medi News

    PNEUBEVAX 14® Receives WHO Pre-Qualification, Offering Broadest PCV Coverage in India

    The Indian Practitioner -
    1...123124125...304Page 124 of 304

    Current Issue

    © Maintained and managed by Blockdale Media LLP